Ziyi Xu

Luoyang, 471003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Reprogramming the tumor microenvironment with oxygen-driven nanomotors for cuproptosis-enhanced immunotherapy.

Reprogramming the tumor microenvironment with oxygen-driven nanomotors for cuproptosis-enhanced immunotherapy.

Journal: Materials today. Bio

Published: June 18, 2026

A Transient Receptor Potential-related Gene Model for the Prognostic Assessment and Drug Sensitivity Prediction in Osteosarcoma.

A Transient Receptor Potential-related Gene Model for the Prognostic Assessment and Drug Sensitivity Prediction in Osteosarcoma.

Journal: Current medicinal chemistry

Published: April 20, 2026

RNA modifications in cancer: regulators of tumor evolution and therapeutic response.

RNA modifications in cancer: regulators of tumor evolution and therapeutic response.

Journal: Molecular cancer

Published: April 12, 2026

Breaking the vicious cycle of diabetic wounds with an exosome-engineered dual-responsive microneedle patch.

Breaking the vicious cycle of diabetic wounds with an exosome-engineered dual-responsive microneedle patch.

Journal: Materials today. Bio

Published: March 01, 2026

Advances in research on RNA methylation and its role in the immune microenvironment of gastrointestinal tumors.

Advances in research on RNA methylation and its role in the immune microenvironment of gastrointestinal tumors.

Journal: Frontiers in cell and developmental biology

Published: December 24, 2025

Regulation of RNA methylation linked to drug resistance in gastric cancer.

Regulation of RNA methylation linked to drug resistance in gastric cancer.

Journal: Frontiers in cell and developmental biology

Published: November 06, 2025

METTL1-mediated m7G modification of ASNS mRNA regulates asparagine metabolism reprogramming to promote hepatocellular carcinoma progression.

METTL1-mediated m7G modification of ASNS mRNA regulates asparagine metabolism reprogramming to promote hepatocellular carcinoma progression.

Journal: Oncogene

Published: October 31, 2025

Identification of prognostic biomarkers for hepatocellular carcinoma based on the m6A RNA modification.

Identification of prognostic biomarkers for hepatocellular carcinoma based on the m6A RNA modification.

Journal: International journal of immunopathology and pharmacology

Published: September 27, 2025

RNA modifications: roles in immune cell biology and tumor regulation.

RNA modifications: roles in immune cell biology and tumor regulation.

Journal: Cancer cell international

Published: September 23, 2025

RNA modifications and cancer ferroptosis.

RNA modifications and cancer ferroptosis.

Journal: Cancer cell international

Published: September 17, 2025

Prognostic modeling and immune infiltration analysis in hepatocellular carcinoma using glutathione metabolism-associated genes.

Prognostic modeling and immune infiltration analysis in hepatocellular carcinoma using glutathione metabolism-associated genes.

Journal: European journal of medical research

Published: August 14, 2025

Integrating CyTOF with scRNA-seq reveals that Cyclovirobuxine D inhibits HCC progression through hepatic immune microenvironment remodeling.

Integrating CyTOF with scRNA-seq reveals that Cyclovirobuxine D inhibits HCC progression through hepatic immune microenvironment remodeling.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: July 20, 2025

Showing 1-12 of 15

Last Updated: 09/26/2026